CBM588
osel,miyarisan
['rcc,(-irccs),(-srcc),(-urcc)', 'cbm588']
characterization of the microbial resistome in a prospective trial of cbm588 in (mrcc) offers mechanism for interplay between antibiotic (abx) use and immune checkpoint inhibitor (ici) activity. i am thrilled by this line of research #asco22 
Director at LACOG-GU (Latin American Coop. Oncology Group). Genitourinary Oncologist at Oncologia D’Or, Brazil. Following or RT doesn’t mean endorsement